Kathy Eddy Joins BioConvergence LLC
Published: Jul 22, 2011
Ms. Eddy has over 25 years of experience in finance with a concentration in taxation. In her most recent position as Director of Federal Tax and Global Tax Process with Eli Lilly and Company and its subsidiaries her responsibilities included Sarbanes Oxley compliance, mergers and acquisitions, income tax compliance, tax accounting and tax issue resolution. She also provided oversight for the management and planning of global tax processes including the tax research library and tax software. Ms. Eddy received her BA degree from Franklin College of Indiana and her MBA degree from Indiana University.
We’re fortunate to have someone with Kathy’s experience, expertise and vision to join our team," said Alisa Wright, Chief Executive Officer. "She will work closely with our leadership team and business groups in aligning and expanding our capabilities to better serve our clients." BioConvergence welcomes Ms. Eddy to their team of experts and looks forward to the leadership, experience, and knowledge she brings to the company.
About BioConvergence LLC
BioConvergence is a small, woman-owned business in Bloomington, Indiana providing services for the pharmaceutical and biotech industries in support of product development and clinical supplies. It specializes in formulation, lyophilization, and analytical development, supply chain and materials management, clinical trial materials manufacturing and packaging, quality control testing, and consulting services. They are a leader in the industry offering a secure E-Transparency® System giving clients access to their information 24/7 encompassing real-time visibility to all data collected and worked performed. BioConvergence demonstrates that growing a successful business includes serving its clients with services they desire, being dedicated to the health and well-being of its employees, partners, and community, and ultimately being committed to improving the lives of the patients its clients serve. To learn more about BioConvergence and its services visit www.bioc.us or call +1 812 961 1700.